Newsroom

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL), even among those ineligible for the previous standard of care, high-dose chemotherapy followed by an autologous stem cell transplant (ASCT). Results were shared from the combined analysis of four-year data from the la...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced primary data from the pivotal Phase 3 EPCORE® FL-1 study evaluating fixed duration EPKINLY® (epcoritamab-bysp) in combination with rituximab and lenalidomide (EPKINLY + R2) in adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The study showed that treatment with EPKINLY + R2 reduced the risk of disease progression or death by 79% (HR 0.21, 95% CI: 0.14-0.31, p<0.0001) compared to standard...

RIYADH, Saudi Arabia--(BUSINESS WIRE)--Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the following medicines and indications have been renewed in the 2025 National Reimbursement Drug List (NRDL) released by China’s National Healthcare Security Administration (NHSA): VYVGART® (efgartigimod alfa injection) is renewed for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive; NUZYRA® (omadacycl...

TENGCHONG, Cina--(BUSINESS WIRE)--Il 2025 Tengchong Scientists Forum ha aperto le porte sabato nella Provincia di Yunnan, nel sudovest della Cina, riunendo scienziati ed esponenti del mondo accademico di grande rilievo per esaminare l'innovazione nei settori di frontiera che comprendono l'intelligenza artificiale, la biodiversità e la tecnologia quantistica. Tra i partecipanti di spicco si distinguono il premio Nobel per la fisica Konstantin Novoselov, il vincitore della Medaglia Fields Efim Ze...

TENGCHONG, China--(BUSINESS WIRE)--Het Tengchong Scientists Forum 2025 ging zaterdag van start in de provincie Yunnan in het zuidwesten van China. Het forum brengt vooraanstaande wetenschappers en academici samen om innovatie te onderzoeken op grensverleggende gebieden, waaronder kunstmatige intelligentie, biodiversiteit en kwantumtechnologie. Opmerkelijke deelnemers zijn onder andere Nobelprijswinnaar Konstantin Novoselov, Fields-medaillewinnaar Efim Zelmanov en Turing Award-winnaar Andrew Chi...

TENGCHONG, Chine--(BUSINESS WIRE)--Le 2025 Tengchong Scientists Forum s’est ouvert samedi dans la province du Yunnan, dans le sud-ouest de la Chine, réunissant des scientifiques et des universitaires de renom afin d’examiner les innovations dans des domaines de pointe tels que l’intelligence artificielle, la biodiversité et la technologie quantique. Parmi les participants notables figurent le lauréat du prix Nobel de physique Konstantin Novoselov, le médaillé Fields Efim Zelmanov et le lauréat...

TENGCHONG, China--(BUSINESS WIRE)--El Foro de Científicos de Tengchong 2025 se inauguró el sábado en la provincia de Yunnan, al suroeste de China, y reunió a destacados científicos y figuras académicas para explorar la innovación en campos de vanguardia, como la inteligencia artificial, la biodiversidad y la tecnología cuántica. Entre los participantes más destacados se encuentran el premio nobel de física Konstantin Novoselov; Efim Zelmanov, galardonado con la Medalla Fields, y el ganador del...

TENGCHONG, China--(BUSINESS WIRE)--Das Tengchong Scientists Forum 2025 öffnete am Samstag in der südwestchinesischen Provinz Yunnan seine Pforten und versammelt führende Wissenschaftler und Akademiker, um Innovationen in Grenzbereichen wie künstlicher Intelligenz, Biodiversität und Quantentechnologie zu untersuchen. Zu den prominenten Teilnehmern gehören der Nobelpreisträger für Physik, Konstantin Novoselov, der Fields-Medaillengewinner Efim Zelmanov und der Turing-Preisträger Andrew Chi-Chih Y...

MEMPHIS, Tenn.--(BUSINESS WIRE)--The spirit of Memphis was on full display this weekend as tens of thousands of runners, patient families, doctors, researchers, support staff, and volunteers came together for the 2025 St. Jude Memphis Marathon® Weekend presented by Juice Plus+®. In its 24th year, the event raised nearly $16 million, transforming the city into a celebration of courage, community and hope, all to benefit the lifesaving mission of St. Jude Children’s Research Hospital®. From the e...